Amerise Biosciences

₹0.6 0 | 0%

WEBSITE BSE:531681 NSE : AMERISE 18 May, 12:50

Market Cap ₹4 Cr.

Stock P/E -21.9

P/B 0.8

Current Price ₹0.6

Book Value ₹ 0.8

Face Value 1

52W High ₹0.9

Dividend Yield 0%

52W Low ₹ 0.5

Edit Ratio

Amerise Biosciences Research see more...

Overview Inc. Year: 1984Industry: Finance - Investment

Amerise Biosciences Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Amerise Biosciences Quarterly Results

#(Fig in Cr.)	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	2	2	7	0	0	0	0	0	0	0
Other Income	-0	0	0	0	0	0	0	0	0	0
Total Income	1	2	7	0	0	0	0	0	0	0
Total Expenditure	1	2	6	0	0	0	0	0	0	0
Operating Profit	0	0	0	-0	-0	-0	-0	-0	-0	-0
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	0	0	0	-0	-0	-0	-0	-0	-0	-0
Provision for Tax	0	0	0	0	0	0	0	0	0	0
Profit After Tax	0	0	0	-0	-0	-0	-0	-0	-0	-0
Adjustments	0	-0	0	-0	-0	0	0	0	0	0
Profit After Adjustments	0	0	0	-0	-0	-0	-0	-0	-0	-0
Adjusted Earnings Per Share	0	0.1	0	-0	-0	-0	-0	-0	-0	-0

Amerise Biosciences Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Net Sales	0	0	0	0	0	0	1	0	0	9	0
Other Income	0	0	0	0	0	0	0	0	0	1	0
Total Income	0	0	0	0	0	0	1	0	0	10	0
Total Expenditure	0	0	0	0	1	0	1	0	0	9	0
Operating Profit	-0	-0	-0	-0	-1	-0	0	-0	-0	1	-0
Interest	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	-0	-0	-0	-0	-1	-0	0	-0	-0	1	-0
Provision for Tax	0	0	0	0	0	0	0	0	0	0	0
Profit After Tax	-0	-0	-0	-0	-1	-0	0	-0	-0	1	-0
Adjustments	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	-0	-0	-0	-0	-1	-0	0	-0	-0	1	-0
Adjusted Earnings Per Share	-0	-0	-0	-0	-0.1	-0	0	-0	-0.1	0.1	-0

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-100%	0%	0%	0%
Operating Profit CAGR	-100%	0%	0%	0%
PAT CAGR	-100%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-13%	-28%	-6%	-20%
ROE Average	-2%	1%	-0%	-2%
ROCE Average	-2%	1%	-0%	-2%

Amerise Biosciences Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	7	7	7	7	6	6	6	5	5	6	6
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	3	1	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0	0	0
Total Current Liabilities	0	0	0	0	0	0	0	1	1	6	0
Total Liabilities	9	7	7	7	6	6	6	6	6	12	6
Fixed Assets	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	5	5	3	6	3	3	1	6	6	6	6
Total Current Assets	5	2	4	0	3	3	4	0	0	6	0
Total Assets	9	7	7	7	6	6	6	6	6	12	6

Amerise Biosciences Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	0	0	0	0	0	0	0	0	0	0
Cash Flow from Operating Activities	-5	3	0	1	-4	-0	-2	5	-0	0	-0
Cash Flow from Investing Activities	5	-1	0	-1	4	0	2	-5	0	-0	0
Cash Flow from Financing Activities	0	-2	-1	0	0	0	0	0	0	0	0
Net Cash Inflow / Outflow	0	0	-0	0	-0	-0	-0	0	-0	-0	0
Closing Cash & Cash Equivalent	0	0	0	0	0	0	0	0	0	0	0

Amerise Biosciences Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-0	-0	-0.01	-0	-0.14	-0	0	-0.02	-0.05	0.08	-0.02
CEPS(Rs)	-0	-0	-0.01	-0	-0.14	-0	0	-0.02	-0.05	0.08	-0.02
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	1	1	0.99	0.99	0.85	0.84	0.84	0.82	0.77	0.85	0.84
Core EBITDA Margin(%)	0	0	0	0	0	0	0.35	0	0	-0.22	0
EBIT Margin(%)	0	0	0	0	0	0	0.35	0	0	6.1	0
Pre Tax Margin(%)	0	0	0	0	0	0	0.35	0	0	6.1	0
PAT Margin (%)	0	0	0	0	0	0	0.35	0	0	6.1	0
Cash Profit Margin (%)	0	0	0	0	0	0	0.35	0	0	6.1	0
ROA(%)	-0.34	-0.32	-0.69	-0.43	-15.43	-0.38	0.07	-2.56	-5.79	6.24	-1.35
ROE(%)	-0.47	-0.39	-0.72	-0.43	-15.5	-0.38	0.07	-2.71	-6.41	10.24	-2.13
ROCE(%)	-0.33	-0.31	-0.68	-0.43	-15.5	-0.38	0.07	-2.7	-6.41	10.17	-2.1
Receivable days	0	0	0	0	0	0	1106.76	0	0	251.89	0
Inventory Days	0	0	0	0	0	0	0	0	0	0	0
Payable days	0	0	0	0	0	0	0	0	0	138.11	0
PER(x)	0	0	0	0	0	0	0	0	0	16.37	0
Price/Book(x)	5.97	0	0	0	1.11	0	0	1	2.14	1.59	0.84
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	0	0	0	0	0	0	5.58	0	0	1.01	0
EV/Core EBITDA(x)	-1352.58	-274.6	-140.18	-232.78	-6.56	-309.66	1602.26	-36.26	-32.3	16.48	-39.57
Net Sales Growth(%)	0	0	0	0	0	0	0	-100	0	0	-100
EBIT Growth(%)	-3.31	16.74	-79.68	39.83	-3239.67	97.74	119.37	-3717.02	-126.52	263.13	-121.62
PAT Growth(%)	-3.48	16.67	-80.41	40.33	-3239.67	97.74	119.37	-3725.15	-126.15	262.91	-121.65
EPS Growth(%)	-3.48	15.75	-77.5	40.02	-3239.67	97.75	118.75	-3866.67	-125.66	262.94	-121.66
Debt/Equity(x)	0.41	0.09	0	0	0	0	0	0	0	0.01	0.02
Current Ratio(x)	1233.39	1788.32	1845.13	7.93	57.32	109.1	180.09	0.04	0.04	0.99	0.37
Quick Ratio(x)	1233.39	1788.32	1845.13	7.93	57.32	109.1	180.09	0.04	0.04	0.99	0.37
Interest Cover(x)	-278.33	-225.9	-117.22	0	0	0	0	-445.17	-1631.54	1374	-1188
Total Debt/Mcap(x)	0.07	0	0	0	0	0	0	0	0	0.01	0.02

Amerise Biosciences Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0	0	0	0	0	0	0	0	0	0
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	100	100	100	100	100	100	100	100	100	100
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

Pros

Stock is trading at 0.8 times its book value
Debtor days have improved from 138.11 to 0days.
Company is almost debt free.

Cons

Promoter holding is low: 0%.
Company has a low return on equity of 1% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Amerise Biosciences News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 1900/-

SBI Mutual Fund

Current Price: 300/-

Orbis Financial

Current Price: 300/-

Orbis Financial

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0	0	0	0	0	0	0	0	0	0
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	6.61	6.61	6.61	6.61	6.61	6.61	6.61	6.61	6.61	6.61
Others	0	0	0	0	0	0	0	0	0	0
Total	6.61	6.61	6.61	6.61	6.61	6.61	6.61	6.61	6.61	6.61

Amerise Biosciences

Add Watchlist

Amerise Biosciences Research see more...

Overview Inc. Year: 1984Industry: Finance - Investment

Amerise Biosciences Share Price

Alert Data

Quarterly Price

Peer Comparison

Amerise Biosciences Quarterly Results

Amerise Biosciences Profit & Loss

Growth Rates

Amerise Biosciences Balance Sheet

Amerise Biosciences Cash Flow

Amerise Biosciences Ratios

Amerise Biosciences Shareholding Pattern

Amerise Biosciences News

Top Unlisted Companies & InstaBuy Companies

SBI Mutual Fund

Orbis Financial

Orbis Financial

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!